Codeine is a weak opioid that your body must convert into morphine before it provides meaningful pain relief or cough suppression. That conversion happens in the liver, and how efficiently your liver performs it determines almost everything about your experience with the drug, from whether it works at all to whether it causes dangerous side effects. Here’s what happens at each stage.
How Your Liver Activates Codeine
Codeine is what pharmacologists call a prodrug. On its own, it binds very weakly to the brain’s pain-relief receptors. To actually work, it needs to be chemically reshaped by a specific liver enzyme called CYP2D6. This enzyme strips a small molecular group off codeine and converts it into morphine, which binds to pain receptors with roughly 200 times greater strength than codeine itself.
Once that morphine reaches your brain, it locks onto receptors that dampen pain signals and produce a sense of calm or mild euphoria. These same receptors exist throughout your gut, which is why codeine reliably causes digestive side effects even when it’s doing exactly what it’s supposed to do.
Why Codeine Works Differently for Different People
The CYP2D6 enzyme isn’t equally active in everyone. Your genetics determine how fast or slow you metabolize codeine, and the differences are dramatic. Roughly 40% of the U.S. population carries a gene variant that puts them at one of two extremes: either they convert codeine to morphine too slowly (poor metabolizers) or too quickly (ultra-rapid metabolizers).
If you’re a poor metabolizer, codeine may do almost nothing for your pain. Your body simply can’t produce enough morphine from the dose to make a difference. On the other end, ultra-rapid metabolizers flood their system with morphine faster than expected. They may need less medication for pain control, but they face a higher risk of dangerous side effects, particularly slowed breathing, even at standard doses. In one study, about 34% of patients with either extreme metabolizer type experienced an adverse outcome when prescribed codeine or similar opioids.
Most people fall somewhere in the middle, with normal enzyme activity that produces the intended effect at standard doses. But there’s no way to know your metabolizer status without genetic testing, which is one reason codeine’s risks are harder to predict than those of many other medications.
Pain Relief and Cough Suppression
When codeine is taken by mouth, effects typically begin within 30 to 60 minutes, peak at around one hour, and last four to six hours. For pain, the morphine produced by your liver activates receptors in the brain and spinal cord that reduce the intensity of pain signals reaching your conscious awareness.
For cough, codeine works through a separate mechanism in the brainstem. It suppresses a gating system that controls the cough reflex, essentially raising the threshold for triggering a cough. Doses used for cough suppression typically range from 30 to 60 mg. It’s worth noting that while codeine has long been considered a standard cough suppressant, recent clinical evidence has raised questions about how effective it actually is compared to placebo.
Common Side Effects
Among people taking opioids for chronic pain, about 80% experience at least one side effect. The three most frequent are constipation (affecting roughly 41%), nausea (32%), and drowsiness (29%).
Constipation is the most persistent of these. Opioid receptors in the colon increase fluid absorption and slow the movement of material through the intestines. The result is harder, drier stool and fewer bowel movements, often fewer than three per week. Unlike many other side effects, constipation does not improve with continued use. It stays for as long as you take the medication.
Nausea and vomiting occur because opioids slow gastric emptying, meaning food sits in your stomach longer than usual. This effect tends to fade within days to a few weeks of regular use as your body adjusts. Drowsiness and mental fogginess also typically diminish over time as tolerance to the sedating effects develops.
Respiratory Depression
The most dangerous acute effect of codeine is slowed breathing. Opioids reduce the brain’s automatic drive to breathe, lowering both the rate and depth of each breath. In severe cases, breathing drops below eight breaths per minute and blood oxygen levels fall below 85%, a combination that can lead to organ damage, coma, or death.
This risk increases substantially when codeine is combined with other substances that depress the central nervous system. Alcohol, anti-anxiety medications like benzodiazepines, sleep aids, and certain muscle relaxants all amplify codeine’s effect on breathing. The FDA has issued its strongest warning about combining opioids with benzodiazepines, noting that the combination can cause extreme sedation, respiratory failure, coma, and death. Alcohol carries the same risk and should not be used alongside codeine.
Warning signs of respiratory depression include unusual dizziness, extreme sleepiness, very slow or shallow breathing, and becoming unresponsive. These symptoms require immediate emergency attention.
Tolerance and Physical Dependence
With regular use, your body adapts to codeine’s presence in predictable ways. Tolerance develops as your brain’s opioid receptors become less responsive, meaning you need higher doses to achieve the same level of pain relief. This process can begin within days to weeks of consistent use.
Physical dependence is a separate but related process. Your nervous system recalibrates around the ongoing presence of the drug, so removing it abruptly causes withdrawal. For short-acting opioids like codeine, withdrawal symptoms typically begin 8 to 24 hours after the last dose and last 4 to 10 days. Common symptoms include muscle aches, sweating, anxiety, insomnia, nausea, vomiting, diarrhea, and intense cravings. These symptoms are deeply uncomfortable but rarely life-threatening in otherwise healthy adults.
Physical dependence is not the same as addiction, though they often overlap. Dependence is a predictable physiological response. Addiction involves compulsive use despite harm, and carries additional psychological and behavioral dimensions.
Restrictions for Children and Adolescents
The FDA has placed its strongest restriction on codeine use in children under 12, prohibiting it entirely for both pain and cough in that age group. Children are particularly vulnerable because those who happen to be ultra-rapid metabolizers can accumulate dangerous levels of morphine from standard pediatric doses, with potentially fatal results.
For adolescents between 12 and 18, codeine is not recommended if they are obese or have conditions like obstructive sleep apnea or severe lung disease, all of which increase the risk of breathing problems. Codeine is also contraindicated for anyone under 18 recovering from tonsil or adenoid surgery. Nursing mothers are advised against codeine use because the morphine produced can pass into breast milk and affect the infant.